|
|
Volumn 4, Issue 5, 2003, Pages 385-390
|
|
Update on overactive bladder: pharmacologic approaches on the horizon.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZHYDRYL DERIVATIVE;
BENZOFURAN DERIVATIVE;
BETA 3 ADRENERGIC RECEPTOR;
BOTULINUM TOXIN;
CRESOL;
DARIFENACIN;
DULOXETINE;
MANDELIC ACID DERIVATIVE;
MUSCARINIC RECEPTOR BLOCKING AGENT;
NORTROPANE DERIVATIVE;
OXYBUTYNIN;
PHENYLPROPANOLAMINE;
PYRROLIDINE DERIVATIVE;
THIOPHENE DERIVATIVE;
TOLTERODINE;
TROSPIUM CHLORIDE;
BLADDER DISEASE;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG DOSAGE FORM;
DRUG FORMULATION;
DRUG SCREENING;
HUMAN;
INTRADERMAL DRUG ADMINISTRATION;
INTRAVESICAL DRUG ADMINISTRATION;
METHODOLOGY;
MICTURITION DISORDER;
ORAL DRUG ADMINISTRATION;
REVIEW;
TREATMENT OUTCOME;
ADMINISTRATION, CUTANEOUS;
ADMINISTRATION, INTRAVESICAL;
ADMINISTRATION, ORAL;
BENZHYDRYL COMPOUNDS;
BENZOFURANS;
BOTULINUM TOXINS;
CRESOLS;
DOSAGE FORMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG COMPOUNDING;
DRUG EVALUATION;
HUMANS;
MANDELIC ACIDS;
MUSCARINIC ANTAGONISTS;
NORTROPANES;
PHENYLPROPANOLAMINE;
PYRROLIDINES;
RECEPTORS, ADRENERGIC, BETA-3;
THIOPHENES;
TREATMENT OUTCOME;
URINARY BLADDER DISEASES;
URINATION DISORDERS;
|
|
EID: 0642367799
PISSN: 15272737
EISSN: None
Source Type: Journal
DOI: 10.1007/s11934-003-0013-3 Document Type: Review |
|
Times cited : (11)
|
|
References (42)
|
